Effects of bezafibrate on dyslipidemia with cholestasis in children with familial intrahepatic cholestasis–1 deficiency manifesting progressive familial intrahepatic cholestasis
Authors:
- 1 January 2009
- journal article
- Published by Elsevier in Metabolism
- Vol. 58 (1) , 48-54
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Evaluation of risk for atherosclerosis in Alagille syndrome and progressive familial intrahepatic cholestasis: Two congenital cholestatic diseases with different lipoprotein metabolismsThe Journal of Pediatrics, 2005
- Multidrug resistance3 is in situ detected in the liver of patients with primary biliary cirrhosis, and induced in human hepatoma cells by bezafibrateHepatology Research, 2004
- Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARα-mediated redistribution of ABCB4Journal of Lipid Research, 2004
- FIC1 Disease: A Spectrum of Intrahepatic Cholestatic DisordersSeminars in Liver Disease, 2001
- Bezafibrate Increases Preβ1-HDL at the Expense of HDL 2b in HypertriglyceridemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Premature Atherosclerosis in Patients with Familial Chylomicronemia Caused by Mutations in the Lipoprotein Lipase GeneNew England Journal of Medicine, 1996
- Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.Journal of Clinical Investigation, 1994
- Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Spurious elevation of serum high-density lipoprotein cholesterol in patients with cholestatic liver diseasesBiochemical Medicine and Metabolic Biology, 1991
- Deficiency of Hepatic Lipase Activity in Post‐heparin Plasma in Familial Hyper‐α‐TriglyceridemiaActa Medica Scandinavica, 1986